In contrast to its role in gut barrier homeostasis, where a lack of NR2F6 expression has been observed to cause detrimental effects on intestinal barrier integrity, promoting colitis and chronic intestinal inflammation [20], loss of NR2F6 expression in ECM appears to prevent BBB dysfunction and reduce immune cell infiltration compared with the wild-type control. The gene discussed is NR2F6; the disease is colitis.